A trial to answer an important clinical question, along with studies of novel and repurposed drugs, made news at the American Heart Association’s flagship conference in Chicago late last year.
The hotly anticipated results from a major trial should help to resolve a common clinical question: should patients with significant but stable coronary artery disease begin treatment with medication and lifestyle changes alone or will undergoing an invasive procedure, like stent placement or bypass surgery, along with medical therapy produce better outcomes?
Abbasi J. Cardiovascular Corner—Stable Coronary Artery Disease, An LDL “Vaccine,” and Anti-inflammatories. JAMA. 2020;323(13):1233–1234. doi:10.1001/jama.2019.20983
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: